運達股份(300772.SZ):購置經營科研用房 已完成過户
格隆匯 5 月 6日丨運達股份(300772.SZ)公佈,此前公吿披露,公司於2021年3月8日召開的第四屆董事會第十七次會議審議通過《關於購置經營科研用房暨關聯交易的議案》,因經營發展需要,以自有資金向中節能實業發展有限公司(“中節能實業”)購買位於浙江省杭州市文二路391號的西湖國際科技大廈A座22樓(“標的資產”)作為經營科研用房。
2021年4月30日,中節能實業就標的資產產權轉移事宜辦理完成過户手續,並取得新的編號為D33006944492的《不動產權證書》,證書記載權利人為浙江運達風電股份有限公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.